0001209191-18-056052.txt : 20181024 0001209191-18-056052.hdr.sgml : 20181024 20181024162036 ACCESSION NUMBER: 0001209191-18-056052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181022 FILED AS OF DATE: 20181024 DATE AS OF CHANGE: 20181024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TUFTS LINDA CENTRAL INDEX KEY: 0001388680 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 181136632 MAIL ADDRESS: STREET 1: 222 BERKELEY STREET CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-22 0 0001169245 PhaseBio Pharmaceuticals Inc PHAS 0001388680 TUFTS LINDA C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PARKWAY, SUITE 30 MALVERN PA 19355 1 0 0 0 Common Stock 2018-10-22 4 C 0 577486 A 577486 I By Fletcher Spaght Ventures II, LP Common Stock 2018-10-22 4 P 0 12682 5.00 A 590168 I By Fletcher Spaght Ventures II, LP Common Stock 2018-10-22 4 C 0 58152 A 58152 I By FSV II, LP Common Stock 2018-10-22 4 P 0 1277 5.00 A 59429 I By FSV II, LP Common Stock 2018-10-22 4 C 0 275055 A 275055 I By FSV II-B, LP Common Stock 2018-10-22 4 P 0 6041 5.00 A 281096 I By FSV II-B, LP Warrants to Purchase Series B Preferred Stock 0.12 2018-10-22 4 M 0 7053 0.00 D Series B Preferred Stock 7053 0 I By Fletcher Spaght Ventures II, LP Series B Preferred Stock 2018-10-22 4 M 0 7053 0.12 A Common Stock 7053 347420 I By Fletcher Spaght Ventures II, LP Series B Preferred Stock 2018-10-22 4 S 0 170 5.00 D Common Stock 170 347250 I By Fletcher Spaght Ventures II, LP Warrants to Purchase Series B Preferred Stock 0.12 2018-10-22 4 M 0 710 0.00 D Series B Preferred Stock 710 0 I By FSV II, LP Series B Preferred Stock 2018-10-22 4 M 0 710 0.12 A Common Stock 710 34986 I By FSV II, LP Series B Preferred Stock 2018-10-22 4 S 0 18 5.00 D Common Stock 18 34968 I By FSV II, LP Warrants to Purchase Series B Preferred Stock 0.12 2018-10-22 4 M 0 3359 0.00 D Series B Preferred Stock 3359 0 I By FSV II-B, LP Series B Preferred Stock 2018-10-22 4 M 0 3359 0.12 A Common Stock 3359 165476 I By FSV II-B, LP Series B Preferred Stock 2018-10-22 4 S 0 81 5.00 D Common Stock 81 165395 I By FSV II-B, LP Warrants to Purchase Series C-1 Preferred Stock 0.12 2018-10-22 4 M 0 9847 0.00 D Series C-1 Preferred Stock 9847 0 I By Fletcher Spaght Ventures II, LP Series C-1 Preferred Stock 2018-10-22 4 M 0 9847 0.12 A Common Stock 9847 47377 I By Fletcher Spaght Ventures II, LP Series C-1 Preferred Stock 2018-10-22 4 S 0 237 5.00 D Common Stock 237 47140 I By Fletcher Spaght Ventures II, LP Warrants to Purchase Series C-1 Preferred Stock 0.12 2018-10-22 4 M 0 991 0.00 D Series C-1 Preferred Stock 991 0 I By FSV II, LP Series C-1 Preferred Stock 2018-10-22 4 M 0 991 0.12 A Common Stock 991 4770 I By FSV II, LP Series C-1 Preferred Stock 2018-10-22 4 S 0 24 5.00 D Common Stock 24 4746 I By FSV II, LP Warrants to Purchase Series C-1 Preferred Stock 0.12 2018-10-22 4 M 0 4690 0.00 D Series C-1 Preferred Stock 4690 0 I By FSV II-B, LP Series C-1 Preferred Stock 2018-10-22 4 M 0 4690 0.12 A Common Stock 4690 22565 I By FSV II-B, LP Series C-1 Preferred Stock 2018-10-22 4 S 0 113 5.00 D Common Stock 113 22452 I By FSV II-B, LP Series AA Preferred Stock 2018-10-22 4 C 0 119408 0.00 D Common Stock 119408 0 I By Fletcher Spaght Ventures II, LP Series AA Preferred Stock 2018-10-22 4 C 0 12025 0.00 D Common Stock 12025 0 I By FSV II, LP Series AA Preferred Stock 2018-10-22 4 C 0 56874 0.00 D Common Stock 56874 0 I By FSV II-B, LP Series B Preferred Stock 2018-10-22 4 C 0 347250 0.00 D Common Stock 347250 0 I By Fletcher Spaght Ventures II, LP Series B Preferred Stock 2018-10-22 4 C 0 34968 0.00 D Common Stock 34968 0 I By FSV II, LP Series B Preferred Stock 2018-10-22 4 C 0 165395 0.00 D Common Stock 165395 0 I By FSV II-B, LP Series C-1 Preferred Stock 2018-10-22 4 C 0 47140 0.00 D Common Stock 47140 0 I By Fletcher Spaght Ventures II, LP Series C-1 Preferred Stock 2018-10-22 4 C 0 4746 0.00 D Common Stock 4746 0 I By FSV II, LP Series C-1 Preferred Stock 2018-10-22 4 C 0 22452 0.00 D Common Stock 22452 0 I By FSV II-B, LP Series D Preferred Stock 2018-10-22 4 C 0 63688 0.00 D Common Stock 63688 0 I By Fletcher Spaght Ventures II, LP Series D Preferred Stock 2018-10-22 4 C 0 6413 0.00 D Common Stock 6413 0 I By FSV II, LP Series D Preferred Stock 2018-10-22 4 C 0 30334 0.00 D Common Stock 30334 0 I By FSV II-B, LP Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date. FSA II, LLC is the general partner of the general partner of Fletcher Spaght Ventures II, LP and FSV II-B, LP and the manager of the general partner of FSV II, LP. The reporting person is a managing member of FSA II, LLC and disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering. The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering. /s/ Darren K. DeStefano, Attorney-in-Fact 2018-10-24